These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38335423)

  • 1. Primary clostridium difficile infection in patients with ulcerative colitis: Case report and literature review.
    Gao X; Zhou H; Hu Z; Wang Q; Chen Y; Zh F; Zhou G
    Medicine (Baltimore); 2024 Feb; 103(6):e36693. PubMed ID: 38335423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal Microbiota Transplantation in Recurrent NAP1/B1/027 Clostridium Difficile Infection (CDI) Resistant to Vancomycin and Metronidazole in a Patient with Ulcerative Colitis (UC): A Case Report.
    Preda CM; Meianu C; Sandra I; Becheanu G; Dumbrava M; Manuc M; Diculescu M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):563-7. PubMed ID: 30044904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulcerative colitis worsened after Clostridium difficile infection: efficacy of infliximab.
    Seicean A; Moldovan-Pop A; Seicean R
    World J Gastroenterol; 2014 May; 20(17):5135-40. PubMed ID: 24803831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.
    Garcia PG; Chebli LA; da Rocha Ribeiro TC; Gaburri PD; de Lima Pace FH; Barbosa KVBD; Costa LA; de Almeida Cruz W; de Assis IC; Moraes BRM; Zanini A; Chebli JMF
    Int J Colorectal Dis; 2018 Sep; 33(9):1285-1294. PubMed ID: 29926235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel Disease.
    Horton HA; Dezfoli S; Berel D; Hirsch J; Ippoliti A; McGovern D; Kaur M; Shih D; Dubinsky M; Targan SR; Fleshner P; Vasiliauskas EA; Grein J; Murthy R; Melmed GY
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5054-9. PubMed ID: 24913174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Lee MR; Kim ES
    Korean J Gastroenterol; 2022 Aug; 80(2):66-71. PubMed ID: 36004633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant Clostridioides difficile and Edwardsiella tarda Infection in a Patient with Ulcerative Colitis.
    Fukuda H; Shinzaki S; Doi A; Yoshii S; Yoshioka T; Tsujii Y; Inoue T; Sakamori R; Takehara T
    Intern Med; 2023 Jun; 62(12):1757-1763. PubMed ID: 36288985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis.
    Shoaei P; Shojaei H; Jalali M; Khorvash F; Hosseini SM; Ataei B; Vakili B; Ebrahimi F; Tavakoli H; Esfandiari Z; Weese JS
    BMC Infect Dis; 2019 Apr; 19(1):361. PubMed ID: 31039738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis.
    Porcari S; Severino A; Rondinella D; Bibbò S; Quaranta G; Masucci L; Maida M; Scaldaferri F; Sanguinetti M; Gasbarrini A; Cammarota G; Ianiro G
    J Autoimmun; 2023 Dec; 141():103033. PubMed ID: 37085337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
    Wultańska D; Banaszkiewicz A; Radzikowski A; Obuch-Woszczatyński P; Młynarczyk G; Brazier JS; Pituch H; van Belkum A
    Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1265-70. PubMed ID: 20577773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients.
    Lam AY; Gutin LS; Nguyen Y; Velayos FS
    Dig Dis Sci; 2020 Nov; 65(11):3111-3115. PubMed ID: 32749638
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
    Lei DK; Ollech JE; Andersen M; Weisshof R; Zmeter N; Sossenheimer P; Rubin DT
    Am J Gastroenterol; 2019 Dec; 114(12):1904-1908. PubMed ID: 31714359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological features of Clostridioides difficile colitis in patients with inflammatory bowel disease.
    Sweeney JR; Crawford CV; Yantiss RK
    Histopathology; 2022 Sep; 81(3):312-318. PubMed ID: 35758181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence and morbidity of Clostridium difficile infection among hospitalized patients with inflammatory bowel disease: A prospective observational cohort study.
    Chen XL; Deng J; Chen X; Wan SS; Wang Y; Cao Q
    J Dig Dis; 2019 Sep; 20(9):460-466. PubMed ID: 31278840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridioides difficile associated peritonitis in peritoneal dialysis patients - a case series based review of an under-recognized entity with therapeutic challenges.
    Shah KJ; Cherabuddi K; Pressly KB; Wright KL; Shukla A
    BMC Nephrol; 2020 Mar; 21(1):76. PubMed ID: 32131755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation.
    Tubau-Juni N; Bassaganya-Riera J; Leber AJ; Alva SS; Hontecillas R
    Inflamm Bowel Dis; 2024 Jan; 30(1):103-113. PubMed ID: 37436905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prevalence and Risk Factors of
    Song EM; Choi A; Kim S; Jung SH
    J Korean Med Sci; 2023 Dec; 38(47):e359. PubMed ID: 38050911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends and risk factors associated with Clostridioides difficile infections in hospitalized patients with inflammatory bowel disease.
    Spartz EJ; DeDecker LC; Fansiwala KM; Noorian S; Roney AR; Hakimian S; Sauk JS; Chen PH; Limketkai BN
    Aliment Pharmacol Ther; 2024 Jan; 59(1):89-99. PubMed ID: 37873878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Gupta A; Wash C; Wu Y; Sorrentino D; Nguyen VQ
    Dig Dis Sci; 2021 Feb; 66(2):547-553. PubMed ID: 32207033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.